Scottsdale, AZ (January 9, 2020) – VirTrial announced today that it has been selected as a winner in this year’s Fierce Innovation Awards – LifeSciences Edition, a peer reviewed awards program from the publisher of FierceBiotech and FiercePharma. The competition...
Scottsdale, AZ (December 12, 2019) – VirTrial, a portfolio company of Kinderhook Industries, LLC, announced today the acquisition of SnapMD, an industry-leading provider of telemedicine tools and services that improve patient engagement. The acquisition bolsters...
Scottsdale, AZ (October 10, 2019) – VirTrial today announced an alliance with Pratia, the largest network of clinical research centers in Europe. All Pratia research centers have completed VirTrial’s Virtual Trial Capable training, making them the first site...
Scottsdale, AZ (October 9, 2019) – VirTrial has been awarded an FDA-approved hybrid decentralized clinical trial (DCT) with Hope Biosciences. The study provides Hope Biosciences’ autologous, adipose-derived culture-expanded mesenchymal stem cells (HB-adMSC’s)...
Scottsdale, AZ (September 16, 2019) – VirTrial today announced a collaboration with hyperCORE International, the largest independent clinical research site network in the world. hyperCORE includes more than 80 sites across five countries and two continents and...
Scottsdale, AZ (August 19, 2019) – VirTrial today announced a training and certificate program to help clinical research professionals prepare for hybrid decentralized clinical trials (DCT) which include a combination of virtual and in-person visits. The program...
